Biomedical Regulations & Ethics
Infographic: Most Americans still trust scientists
It’s easy to look around right now and conclude that popular public opinion has turned against scientists. Twitter hashtags have ...
Coronavirus rekindles age-old debate: Should human genes be patentable?
The sudden surge in the demand for a vaccine has seen the biotechnology industry rush to innovation and testing, which, ...
Infographic: Racing to create affordable at-home test for COVID-19
To stretch beyond the lab, test developers are racing to produce next-stage technologies that could allow for rapid widespread testing ...
Hydroxychloroquine trials halted after World Health Organization cites ‘significantly higher risk of death’ for COVID-19 patients
The World Health Organization has suspended testing of the malaria drug hydroxychloroquine after a study published in The Lancet reported ...
Accidental side effect: COVID-19 pandemic could give polio ‘a fresh start’
The world’s total number of confirmed Covid-19 cases is closing in on 5 million. But an accidental side effect of ...
‘Automation is in a tailspin’: How the pandemic has disrupted AI’s ability to understand us
When covid-19 hit, we started buying things we’d never bought before. The shift was sudden: the mainstays of Amazon’s top ...
Experimental Parkinson’s treatment draws ethics scrutiny with wealthy donor selected as first patient
A secretive experiment revealed [May 12], in which neurosurgeons transplanted brain cells into a patient with Parkinson’s disease, made medical ...
Video: There were objections to Spanish flu lockdowns too. Bad things happened when critics got their way
During the Spanish flu era, officials pushing public health mandates to stop the pandemic in its tracks were met with ...
Viewpoint: US government’s coronavirus response a ‘living nightmare’
It sounds like the U.S. Department of Health and Human Services has become completely dysfunctional. The Secretary, Dr. Azar (ex-lobbyist ...
First, we need a coronavirus vaccine. Then we need to figure out who gets it first
Several drugmakers that have been building up their capabilities to make coronavirus vaccines, have pledged to deliver millions of doses ...
Conflict of Interest? Whistleblower alleges study by Stanford’s John Ioannidis critical of lockdown funded by wealthy corporate donor critical of lockdown
A highly influential coronavirus antibody study was funded in part by David Neeleman, the JetBlue Airways founder and a vocal ...
From bioterror to bioerror: Who’s afraid of biohacking?
In March, amateur scientists in Sydney announced they had created a COVID-19 test kit that is simpler, faster, and cheaper ...
Viewpoint: We can’t let the coronavirus open a ‘back door’ to eugenics
The NHS response to Covid-19 has been incredible. It has shown the strong commitment by the medical profession and society ...
A right to know? Should children be told when a parent’s genetic test reveals hereditary risks?
What are the legal, professional and ethical, duties or responsibilities of researchers and clinicians in handling genetic testing and the ...
Abbott expects to ship 90 million coronavirus antibody tests over next two months after FDA grants emergency approval
The Food and Drug Administration granted emergency use authorization for Abbott Laboratories’ new coronavirus test that detects Covid-19 antibodies.... Abbott ...
Podcast: We need a vaccine ‘Manhattan Project’ to defeat COVID-19
The only way to truly end the novel coronavirus pandemic is to develop an effective vaccine. And while there are ...
Viewpoint: Medical ethics shouldn’t stop coronavirus vaccine researchers from experimenting on healthy people
The pandemic has thrown previous moral assumptions into disarray. ... Research ethics normally prohibits exposing human subjects to significant risk ...
Podcast: GMOs = witchcraft? ‘Big Ag’ didn’t cause coronavirus; Remdesivir for COVID-19
We finally have a drug to treat COVID-19 in remdesivir, but how well does it work? Anti-GMO activists have blamed ...
‘Money being made from people’s suffering’: Selling blood samples from coronavirus survivors
Some biotech companies are cashing in on the race to produce coronavirus antibody tests, taking blood samples from people who ...
‘Impenetrable medical jargon’: Why retooling ClinicalTrials.gov should be a priority
Millions of people visit ClinicalTrials.gov each year to find a trial that they or a loved one might be eligible ...
Viewpoint: Anti-vax group says ‘the elite’ are using COVID-19 to usher in a ‘techno-communist global government’
Children's Health Defense says governments and corporations are using the coronavirus (SARS-COV-2) to advance a "global immunization agenda." The anti-vaccine ...
Shedding light on ‘bizarre’ 1930s procedure in which doctors injected malaria into human brains
A new paper in a neurosurgery journal sheds light on one of the most bizarre and shocking medical procedures ever ...
Is the lockdown an overreaction? Uproar over epidemiologist John Ioannidis’ study minimizing coronavirus risks
For his Covid-19 work, the Stanford scientist John Ioannidis is being accused of the same bad science he has criticized ...
Coronavirus ‘immunity passports’? Why it’s too early to know whether survivors are safe
Policymakers have another reason to scramble to deploy antibody tests: they could indicate whether someone is immune to SARS-CoV-2. With ...
Seeking mainstream acceptance for psychedelic drugs: Will entrepreneurs ruin it for everyone else?
After spending decades as highly illegal and restricted substances, psilocybin (magic mushrooms), LSD, MDMA, DMT, and other psychedelic drugs are ...
‘Digital’ contact tracing: How would the US react to coronavirus containment effort that tracks our cell phones?
There’s a reason contact tracing has survived the test of time: it works. Thanks to epic efforts at hunting down ...
Viewpoint: US failure to ‘study drugs more quickly’ means more people are dying from coronavirus
When medical historians look back at the Covid-19 pandemic, they will reckon with how the United States, with its vast ...
When coronavirus patients don’t have time to wait: Pandemic forces ethical shift in assessing treatments
Normally, it takes about eight years to move a drug through clinical trials and approval by the US Food and ...
